First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Update

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was the recipient of a significant decline in short interest in the month of March. As of March 13th, there was short interest totaling 17,467 shares, a decline of 65.6% from the February 26th total of 50,788 shares. Based on an average daily volume of 74,513 shares, the days-to-cover ratio is presently 0.2 days. Approximately 1.7% of the shares of the company are sold short.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. High Point Wealth Management LLC acquired a new stake in First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth approximately $26,000. Russell Investments Group Ltd. grew its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% in the third quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after purchasing an additional 158 shares during the last quarter. Rossby Financial LCC increased its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 160.0% during the third quarter. Rossby Financial LCC now owns 169 shares of the company’s stock worth $31,000 after purchasing an additional 104 shares during the period. AG Campbell Advisory LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth approximately $31,000. Finally, Capital Investment Advisory Services LLC lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 63.1% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 181 shares of the company’s stock worth $32,000 after purchasing an additional 70 shares during the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Trading Down 0.8%

Shares of NYSEARCA:FBT traded down $1.52 on Thursday, hitting $197.05. The company had a trading volume of 45,384 shares, compared to its average volume of 215,024. The stock has a market cap of $206.90 million, a price-to-earnings ratio of 21.72 and a beta of 0.65. The stock has a 50 day moving average price of $206.39 and a 200 day moving average price of $200.63. First Trust NYSE Arca Biotechnology Index Fund has a 1-year low of $141.38 and a 1-year high of $224.94.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.